Mobile Trading

OXYGENTA PHARMACEUTICAL LTD.

NSE : NABSE : 524636ISIN CODE : INE102E01018Industry : Pharmaceuticals & DrugsHouse : Private
BSE59.050 (0 %)
PREV CLOSE ( ) 59.05
OPEN PRICE ( ) 63.92
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 818
TODAY'S LOW / HIGH ( )59.05 63.92
52 WK LOW / HIGH ( ) 53.56133.5
Quarters
Select year  
( in Million)
Particulars
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
142.46
151.35
494.67
332.06
Total Expenditure
188.77
219.65
511.5
375.63
PBIDT (Excl OI)
-46.31
-68.3
-16.83
-43.57
Other Income
NA
1.69
0.49
4.88
Operating Profit
-46.31
-66.61
-16.34
-38.69
Interest
9.5
6.28
21.28
3.88
Exceptional Items
NA
-0.12
-2.7
NA
PBDT
-55.81
-73.01
-40.32
-42.57
Depreciation
8.57
8.47
-2.34
7.06
Profit Before Tax
-64.38
-81.48
-37.98
-49.63
Tax
-15.07
-20.42
-16.46
-10.34
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
-49.31
-61.06
-21.52
-39.29
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
0.00
0.00
0.00
0.00
Net Profit
-49.31
-61.06
-21.52
-39.29
Equity Capital
369.84
369.84
369.84
369.84
Face Value (IN RS)
10
10
10
10
Reserves
Calculated EPS
-1.33
-1.65
-0.58
-1.06
Calculated EPS (Annualised)
-5.33
-6.60
-2.32
-4.24
No of Public Share Holdings
15550547
15550547
18077298
18077298
% of Public Share Holdings
42.05
42.05
48.88
48.88
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
-32.50
-45.12
-3.40
-13.12
PBIDTM%
-32.50
-44.01
-3.30
-11.65
PBDTM%
-39.17
-48.23
-8.15
-12.81
PBTM%
-45.19
-53.83
-7.67
-14.94
PATM%
-34.61
-40.34
-4.35
-11.83
 
Notes
Notes
Notes
Notes

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER
© 2018 Ratnakar Securities Pvt. Ltd. All rights reserved.
Designed, Developed & Content Powered by  Accord Fintech Pvt. Ltd.
CLOSE X

Filing complaints on SCORES Easy & quick

  • > Register on SCORES portal (link:https://scores.gov.in)
  • > Mandatory details for filing complaints on SCORES
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • > Benefits:
    • Effective communication
    • Speedy redressal of the grievances
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.